% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • crossroads4040 crossroads4040 Nov 10, 2012 1:20 PM Flag

    GS-7977 + RBV trial (ELECTRON) is a huge failure

    Their brilliance from a PR standpoint is they released the impressive svr4 triple combo data and imbedded the 7997/rbv svr 12 data at the bottom as if it were an afterthought.

    • All will be out on front soon or later.

      Anemia (low hemoglobin content) is a serious side effect of their triple combo.

      [The most common adverse events were headache, fatigue, upper respiratory tract infection and nausea. The most common clinically significant grade 3/4 laboratory abnormality was a hemoglobin reduction.]

109.03-0.37(-0.34%)Oct 8 4:00 PMEDT